Previous Close | 0.2920 |
Open | 0.2920 |
Bid | 0.2868 x 1200 |
Ask | 0.2950 x 900 |
Day's Range | 0.2850 - 0.3000 |
52 Week Range | 0.2460 - 3.7500 |
Volume | |
Avg. Volume | 3,225,998 |
Market Cap | 13.376M |
Beta (5Y Monthly) | 1.79 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2600 |
Earnings Date | Nov 17, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) has announced the publication of Gallup's analysis of results from Take Charge of Canine Cancer, the first-ever nationally representative survey of U.S. dog owners' experiences with the disease.
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the United States Patent and Trademark Office on July 19, 2022 issued a new U.S.
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective August 5, 2022, the Company granted 12,500 restricted stock units (RSUs) to one new employee.